GlassScriptPhysician profile
Thomas M Ratino
NPI 1104030782
$20,329.69
in general payments reported to CMS, 2019-2025
39 companies · $1,280 in 2025
The $1,280 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,900 · 2020: $3,287 · 2021: $2,738 · 2022: $2,231 · 2023: $2,961 · 2024: $2,934 · 2025: $1,280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,234 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,233.65 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $940.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $9,313.25 | 2019-2024 | Senza |
| Boston Scientific Corporation | $1,886.42 | 2019-2024 | Superion Indirect Decompression System, Wavewriter Alpha Prime 16, Intracept |
| Vertiflex, INC. | $1,404.90 | 2019 | |
| Nalu Medical, INC. | $1,294.62 | 2020-2025 | Nalu Neurostimulation System |
| Medtronic USA, INC. | $1,070.60 | 2019-2020 | |
| Spinal Simplicity, LLC | $864.63 | 2022-2025 | Ha Minuteman G3-R |
| Medtronic, INC. | $609.52 | 2021-2025 | Synchromedii, Intellis Adaptivestim |
| Biodelivery Sciences International, INC. | $585.86 | 2019-2021 | |
| Abbvie INC. | $552.39 | 2021-2025 | |
| Painteq LLC | $504.27 | 2021-2024 | Painteq |
| Globus Medical, INC. | $459.61 | 2025 | Omnia, Senza |
| Collegium Pharmaceutical, INC. | $254.99 | 2019-2022 | |
| Allergan, INC. | $241.88 | 2019-2022 | |
| Daiichi Sankyo INC. | $177.00 | 2019 | |
| Vertos Medical, INC. | $138.99 | 2023 | Mild Device Kit |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $118.04 | 2019-2024 | Eterna, Proclaim |
| Hydrocision, INC. | $81.86 | 2024 | Tenjet |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $69.91 | 2021-2025 | Relistor |
| Vertex Pharmaceuticals Incorporated | $69.50 | 2025 | |
| Currax Pharmaceuticals LLC | $63.39 | 2019-2020 | |
| Biotronik Nro, INC. | $61.17 | 2024 | Prospera |
| Amgen INC. | $58.59 | 2019-2021 | |
| Pfizer INC. | $52.26 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $44.89 | 2020 | |
| Pacira Therapeutics, INC. | $43.45 | 2019 | |
| Piramal Critical Care | $42.18 | 2024 | |
| Indivior INC. | $34.95 | 2020 | |
| Vertical Pharmaceuticals, LLC | $28.16 | 2019 | |
| Acclarent, INC | $27.11 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $25.54 | 2019 | |
| Tonix Medicines, INC. | $21.79 | 2025 | Tonmya |
| Forte Bio-Pharma LLC | $21.70 | 2021 | |
| Valinor Pharma, LLC | $18.79 | 2023 | Movantik |
| Scilex Pharmaceuticals INC. | $16.80 | 2019 | |
| Shionogi INC | $15.69 | 2019 | |
| Lundbeck LLC | $15.42 | 2022 | |
| Ibsa Pharma INC. | $14.48 | 2021 | |
| Merck Sharp & Dohme LLC | $12.94 | 2022 | |
| Stimwave Technologies Incorporated | $12.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Ratino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.